HYFT
MindWalk Holdings Corp.
HYFT trails on the overall score without a compensating advantage in the available component scores.
UNH
UnitedHealth Group Incorporated
UNH has the edge over HYFT overall, supported by lower modeled downside and stronger fundamentals.
HYFT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Strong |
HYFT's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
HYFT PE Valuation
HYFT has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
HYFT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect HYFT's losses to grow, with revenue growing.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
HYFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2022 | -$0.75 | -$0.34 |
| Q2 2022 | -$0.60 | -$0.29 |
| Q1 2022 | -$0.65 | -$0.50 |
| Q4 2021 | -$0.57 | -$0.44 |
| Q3 2021 | -$0.41 | -$0.23 |
| Q2 2021 | -$0.31 | -$0.05 |
| Q1 2021 | -$0.15 | +$0.26 |
| Q4 2020 | -$0.13 | +$0.31 |
UNH has the stronger earnings trend. Trailing diluted EPS is down 135% for HYFT versus UNH down 8.5%.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
HYFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.7M | +23% |
| Q2 2026 | $2.9M | -42% |
| Q1 2026 | $2.9M | -32% |
| Q4 2025 | $2.9M | -33% |
| Q3 2025 | $2.2M | -40% |
| Q2 2025 | $4.9M | +8.1% |
| Q1 2025 | $4.3M | -1.1% |
| Q4 2024 | $4.3M | -0.4% |
HYFT's revenue is recovering but still below its 2025 peak: $3M last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -160% | -28 points |
| Q2 2026 | -105% | -78 points |
| Q1 2026 | -95% | +304 points |
| Q4 2025 | -77% | -28 points |
| Q3 2025 | -132% | -42 points |
| Q2 2025 | -27% | +264 points |
| Q1 2025 | -399% | -343 points |
| Q4 2024 | -50% | -16 points |
HYFT's operating margin was −160% last quarter, down 28 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over HYFT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over HYFT on profitability, with a higher operating margin.
HYFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.9M | +$218.3K |
| Q2 2026 | -$1.8M | -$719.4K |
| Q1 2026 | -$2.1M | -$1.2M |
| Q4 2025 | -$2.1M | -$447.1K |
| Q3 2025 | -$3.2M | -$1.7M |
| Q2 2025 | -$1.1M | +$1.6M |
| Q1 2025 | -$924.5K | -$572.3K |
| Q4 2024 | -$1.6M | -$1.4M |
HYFT has burned cash in almost every quarter: −$9M over the past year, against −$7M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over HYFT on cash generation, producing positive trailing cash flow while its opponent burns cash.
HYFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2021 | -7.4x | Net Cash |
| Q4 2020 | -5.5x | Net Cash |
| Q3 2020 | -0.8x | Net Cash |
HYFT has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
HYFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.9 | Neutral |
| Stochastic | 8.2 | Oversold |
HYFT's weekly RSI is 36 (neutral) and its Stochastic is 8 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
HYFT PE vs Healthcare Sector
HYFT has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
HYFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.23 | 19% below |
| 20 week MA | $1.32 | 24% below |
| 50 week MA | $1.45 | 31% below |
| 100 week MA | $1.28 | 22% below |
| 200 week MA | $1.56 | 36% below |
HYFT is in a downtrend: it's below all five of its weekly moving averages, and 36% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over HYFT on trend strength, trading above more of its moving averages.
HYFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.20 | $16.4 | +645% |
| 2021 | $16.4 | $5.36 | -67% |
| 2022 | $5.36 | $5.72 | +6.7% |
| 2023 | $5.72 | $1.71 | -70% |
| 2024 | $1.71 | $0.41 | -76% |
| 2025 | $0.41 | $1.70 | +315% |
| 2026 YTD | $1.70 | $1.00 | -41% |
HYFT's yearly returns have swung widely, from +645% in 2020 to −76% in 2024. It's down 41% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over HYFT on returns for 2026, with the stronger performance.